NCT07192068
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07192068
Title Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene. (AcSe HER2)
Acronym AcSe HER2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut de Cancérologie de l'Ouest ACTIVE_NOT_RECRUITING Angers France Details
Chu Timone RECRUITING Marseille France Details
Institut de Cancérologie de Lorraine ACTIVE_NOT_RECRUITING Vandœuvre-lès-Nancy France Details
Gustave Roussy RECRUITING Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field